Renal cell carcinoma (RCC), the most common type of kidney cancer, is characterized by heterogeneous tumor biology and clinical outcomes. Due to the indeterminate behavior of RCC and the absence of routine biomarkers, it is difficult to identify individuals at risk to develop RCC, and patients who are at high-risk of relapse. There are also […]
Read More